← Open Payments lookup

JILL MILLER: Open Payments

NPI 1710612635 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,434 in 62 payments from 21 companies in 2025. Trend: 2023 $934 · 2024 $1,702 · 2025 $1,434

Food & beverage: $1,389Education: $45
CompanyPaymentsAmount
UCB, Inc.13$249
ABBVIE INC.14$238
Novo Nordisk Inc5$160
Axsome Therapeutics, Inc.2$136
Vanda Pharmaceuticals Inc.4$115
Teva Pharmaceuticals USA, Inc.3$77
Indivior Inc.2$56
Otsuka America Pharmaceutical, Inc.2$48
Lundbeck LLC3$48
Lilly USA, LLC1$45

Products named: VRAYLAR, Ozempic, Briviact, Auvelity, FANAPT, Fintepla, REXULTI, SUBLOCADE.

Industry payments across CA — which companies pay providers there.